Pharmacogenomics continues to be a growing area within the practice of psychiatry, with increasing research, testing availability, and guidance on utilization.   This presentation will provide an up to date review of the current state of evidence on the use of pharmacogenomic testing in psychiatry, including a brief review of pharmacogenomics to level the playing field in the remaining discussion, a contrast of current available testing- commercial versus research, discussion of current utilization of testing in clinical practice- what do the guidelines, clinical trials, and package inserts recommend, and finally how to consider implementation of pharmacogenomics in practice- what should a provider consider prior to ordering and how to interpret the results after receiving them.  Resources will be provided on evidence and interpretation.